Nasal Therapeutics to Enter Migraine Headache Market With New Migraine Relief Homeopathic...

Nasal Therapeutics to Enter Migraine Headache Market With New Migraine Relief
Homeopathic Nasal Spray

LOS ANGELES, Dec. 4 /PRNewswire/ -- Nasal Therapeutics, Inc. announced
today plans to enter the over-the-counter market with a new migraine relief
homeopathic nasal spray. The nasal spray is scheduled to hit the shelves in
the spring of 2008. Nasal Therapeutics, Inc., a subsidiary of Hensley Group,
will launch a line of homeopathic nasal sprays over the next year which will
include remedies for allergy, cold and flu.
"There are approximately thirty million migraine sufferers in the United
States alone", commented Dr. Charles Hensley, Inventor of Zicam Cold Remedy
and Chairman of Hensley Group. "Migraine attacks are severe, come on suddenly
and are often debilitating. Nasal sprays are the delivery system of choice
when it comes to conditions that require rapid relief as they work much faster
than oral formulations."
"The development of the technology behind the new migraine product was
actually quite serendipitous", added Hensley. "While working with
intracellular mediators involved in the development of common colds, our
scientists discovered that these same compounds are putative causative factors
in the genesis and maintenance of migraine attacks. Since they were already
developing nasal delivery compounds to address this therapeutic target, it was
a natural to pursue a therapy for migraine attack," he continued.
About Nasal Therapeutics
Nasal Therapeutics develops and markets homeopathic nasal sprays for such
conditions as common cold, influenza, allergy and migraine. The company is
based on the concept that nasal delivery is the fastest, most effective way to
deliver over-the-counter medicines to the site of therapeutic action. Nasal
therapeutics was incorporated in 2007 and is in the process of closing its
first round of financing.
For further information please contact:
Investor Relations at ir@nasal-theraeutics.com

About Hensley Group
Hensley Group controls a diverse group of subsidiary companies engaged in
Pharmaceuticals, Biotechnology, Cosmetics, Consulting, Media Marketing and
Entertainment and has offices in Los Angeles, Hong Kong, Shanghai and Tokyo.
SOURCE Nasal Therapeutics, Inc.

Natasha Nelson of NN Public Relations, +1-949-548-2227,
Natasha@nnpublicrelations.com, for Nasal Therapeutics, Inc.